Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Archives of Internal Medicine

• Publication date

  2005-06-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.165.11.1304PMID 15956012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trends in heart failure incidence and survival in a community-based population.

  2004cited by this paper
• Erythropoietin in cardiovascular diseases.

  2004cited by this paper
• Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.

  2004cited by this paper
• The cardiovascular effects of erythropoietin.

  2003influential reference
• ANEMIA and congestive heart failure.

  2003cited by this paper
• Anemia and congestive heart failure.

  2003cited by this paper
• Heart failure.

  2003cited by this paper
• Anemia and congestive heart failure.

  2003cited by this paper
• Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure

  2003cited by this paper
• Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure

  2003cited by this paper
• Use of biomarkers in the management of heart failure: are we there yet?

  2003cited by this paper
• Clinical applications of B-type natriuretic peptide (BNP) testing.

  2003cited by this paper
• C‐reactive protein as a predictor of improvement and readmission in heart failure

  2002cited by this paper
• Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study.

  2002cited by this paper
• Long-term trends in the incidence of and survival with heart failure.

  2002cited by this paper
• The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

  2001cited by this paper
• Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

  2001cited by this paper
• Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine.

  1999cited by this paper
• The activated immune system and the renin–angiotensin–aldosterone system in congestive heart failure

  1998cited by this paper
• The activated immune system in congestive heart failure – from dropsy to the cytokine paradigm

  1998cited by this paper
• Circulating interleukin-6 in severe heart failure.

  1997cited by this paper
• Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure.

  1995cited by this paper
• Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles.

  1994cited by this paper
• Elevated level of erythropoietin in congestive heart failure Relationship to renal perfusion and plasma renin

  1993cited by this paper
• Study of serum C-reactive protein concentration in cardiac failure.

  1990cited by this paper
• Heart Failure

  1937cited by this paper

• Anemia Management in the Cardiorenal Patient: A Nephrological Perspective

  2025cites this paper
• Hypoxic regulation of erythropoietin secretion in heart failure patients undergoing elective surgery under cardiopulmonary bypass

  2025cites this paper
• Prognostic Value of Reticulocyte Production Ability in Patients with Chronic Heart Failure.

  2025cites this paper
• Association of endogenous erythropoietin with 10-year risk of all-cause and cardiovascular mortality.

  2025cites this paper
• The treatment of chronic anemia in heart failure: a global approach

  2023cites this paper
• Proteomic Biomarkers in the Cardiorenal Syndrome: Toward Deciphering Molecular Pathophysiology.

  2021cites this paper
• Blood and Bone Epidemiological studies on the association between blood and bone

  2021cites this paper
• Erythropoietin role in the therapeutic management of heart failure patients with anemia

  2020cites this paper
• High Plasma Erythropoietin Predicts Incident Fractures in Elderly Men with Normal Renal Function: The MrOS Sweden Cohort

  2020cites this paper
• Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment

  2020cites this paper
• [Anaemia and iron deficiency in chronic heart failure patients].

  2019cites this paper
• Changes in Tissue Erythropoietin and Some Haematological Parameters in Chronic Kidney Disease Subjects on Blood Transfusion in Port-Harcourt

  2019cites this paper
• Renal Mechanisms and Heart Failure

  2019cites this paper
• Age‐dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients

  2019cites this paper
• Increased red cell distribution width: A novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease.

  2018cites this paper
• Indexes of the erythropoietin level in the blood plasma of chronic heart failure patients with anemia

  2018influential citation
• Erythropoietin response to anaemia in heart failure

  2018cites this paper
• Preoperative Anemia in Cardiac Operation: Does Hemoglobin Tell the Whole Story?

  2018cites this paper
• Renal Dysfunction - a Possible Marker of Severity of Heart Failure

  2018cites this paper
• Higher reticulocyte counts are associated with higher mortality rates in hemodialysis patients: a retrospective single-center cohort study

  2017cites this paper
• Toward a Blood-Borne Biomarker of Chronic Hypoxemia: Red Cell Distribution Width and Respiratory Disease.

  2017cites this paper
• Prognostic significance of endogenous erythropoietin in long‐term outcome of patients with acute decompensated heart failure

  2016cites this paper
• Managing anemia in patients with chronic heart failure ; Is there a new pathway ?

  2016cites this paper
• Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study

  2016influential citation
• Cardiorenal syndrome in chronic kidney disease

  2015cites this paper
• Región Media de la pro-Adrenomedulina como biomarcador pronóstico de mortalidad en pacientes sometidos a ventilación no invasiva en urgencias

  2015cites this paper
• Persistent increase in red cell size distribution width after acute diseases: A biomarker of hypoxemia?

  2015cites this paper
• ФУНКЦИОНАЛЬНАЯ МОДЕЛЬ ПАТОГЕНЕЗA ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА С УЧАСТИЕМ ЭРИТРОПОЭТИНА

  2014cites this paper
• [Correlation between concentration of pathological cytokines and erythropoietin in patients with chronic heart failure with anemic syndrome].

  2014cites this paper
• BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure

  2014cites this paper
• The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions

  2014cites this paper
• The estimation of anemia degree in patients after heart valve replacement and coronary artery bypass surgery

  2013cites this paper
• Pharmacologic Management of the Cardio-renal Syndrome

  2013cites this paper
• Herzinsuffizienz und Anämie

  2013cites this paper
• The Role of Treatment for Anemia as a Therapeutic Target in the Management of Chronic Heart Failure: Insights After RED-HF

  2013cites this paper
• Erythropoietin in cardiac disease: effective or harmful?

  2013cites this paper
• Procjena stupnja anemije u bolesnika nakon zamjene srčanih zalistaka i aortokoronarnog premoštenja The estimation of anemia degree in patients after heart valve replacement and coronary artery bypass surgery

  2013cites this paper
• Erythropoietin, heart disease and global rate

  2013cites this paper
• [Heart failure and anemia].

  2013cites this paper
• NT-ProBNP: marcador biológico útil para monitorización del estado clínico y como factor pronóstico en pacientes ambulatorios portadores de insuficiencia cardíaca sistólica

  2013cites this paper
• Erythropoietin: a future therapy for failing hearts?

  2012cites this paper
• PLEOTROPIC CARDIOPROTECTIVE EFFECTS OF ERYTHROPOIETIN

  2012cites this paper
• Aspetos hematológicos do envelhecimento: anemia fisiológica, patológica, ou ambas?

  2012influential citation
• Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment

  2012cites this paper
• Aspetos hematológicos do envelhecimento

  2012cites this paper
• Global heart failure rates and erythropoietin

  2012cites this paper
• Anaemia in older persons.

  2011cites this paper
• Anaemia and heart failure

  2011cites this paper
• Erythropoietin and the heart: facts and perspectives.

  2011cites this paper
• Serum erythropoietin level and mortality in kidney transplant recipients.

  2011cites this paper
• Anemia: only a marker or an independent predictor of mortality in advanced heart failure?

  2011cites this paper
• Anemia and response to erythropoietin in the cardiorenal syndrome

  2011cites this paper
• Anemia: apenas marcador ou preditor independente de mortalidade na insuficiência cardíaca avançada (40)

  2011cites this paper
• Prediction of Long‐Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15‐Year Prospective Follow‐Up Study

  2010cites this paper
• Pathophysiology of anemia in heart failure.

  2010cites this paper
• Erythropoietin levels in cardiac resynchronization therapy responders.

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus Study

  2010cites this paper
• Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -.

  2010cites this paper
• Relationship of plasma erythropoietin to long-term outcome in acute coronary syndrome.

  2010cites this paper
• The Cardiorenal Syndrome: A Review

  2010cites this paper
• Pathophysiological Mechanisms and Prognostic Significance of Renal Functional Impairment in Cardiac Patients

  2010cites this paper
• Endogenous and exogenous erythropoietin in left ventricular dysfunction

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine Cardiorenal Syndrome New Perspectives

  2010cites this paper
• Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus Study

  2010cites this paper
• Erythropoietin Levels in Cardiac Resynchronization Patients

  2010cites this paper
• Molecular changes in myocardium in the course of anemia or iron deficiency.

  2010cites this paper
• Is there a role for erythropoietin in cardiovascular disease?

  2010cites this paper
• Cardiorenal Syndrome: New Perspectives

  2010cites this paper
• Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin

  2010cites this paper
• Too much, too little, or just right?: untangling endogenous erythropoietin in heart failure.

  2010cites this paper
• Endogenous Erythropoietin and Outcome in Heart Failure

  2010cites this paper
• Bone marrow dysfunction in chronic heart failure patients

  2010cites this paper
• NT-Pro BNP: Biologic marker used for the monitoring of the clinical status and therapy guideline in outpatients with advanced heart failure

  2010cites this paper
• Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED‐HF): a Phase III, anaemia correction, morbidity–mortality trial

  2009cites this paper
• Anämie bei Patienten mit Herzinsuffizienz

  2009cites this paper
• Erythropoietin during hypoglycaemia in type 1 diabetes: relation to basal renin-angiotensin system activity and cognitive function.

  2009cites this paper
• Elevated plasma levels of B-type natriuretic Peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease.

  2009cites this paper
• Anemia in heart failure: pathophysiologic insights and treatment options.

  2009cites this paper
• Managing anaemia in chronic heart failure

  2009cites this paper
• Utilidad de los Péptidos Natriuréticos de Tipo B en la Insuficiencia Cardíaca usefulness of the Type B Natriuretic Peptides in Heart Failure

  2009cites this paper
• Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.

  2009cites this paper
• Anemia: the point of convergence or divergence for kidney disease and heart failure?

  2009cites this paper
• Anemia and heart failure

  2009cites this paper
• Komorbidität: Anämie und Herzinsuffizienz

  2009cites this paper
• Plasma hemoglobin concentration was related to estimated glomerular filtration rate in elderly patients with ischemic cardiomyopathy

  2008cites this paper
• The non‐haematopoietic biological effects of erythropoietin

  2008cites this paper
• Erythropoietin and outcome prediction in patients with heart failure: the plot thickens...

  2008cites this paper
• Traditional and novel approaches to management of heart failure: successes and failures.

  2008cites this paper
• ANEMIA Y COMORBILIDAD COMO FACTORES PRONÓSTICOS DE MORTALIDAD EN LA INSUFICIENCIA CARDIACA Tesis Doctoral presentada por: D. JOSE MARIA RODRIGUEZ FERNANDEZ

  2008cites this paper
• Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure

  2008cites this paper
• Heart failure and anemia: mechanisms and pathophysiology

  2008cites this paper
• Niedokrwistość w niewydolności serca: częste współwystępowanie z niewydolnością nerek, czyli zespół niedokrwistości sercowo-nerkowej

  2008cites this paper
• Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.

  2008cites this paper
• Erythropoietin in cancer: the new face of an old friend.

  2008cites this paper
• Intervention for apoptosis in cardiomyopathy

  2008cites this paper
• The relation between serum erythropoietin level and severity of disease and mortality in patients with chronic heart failure

  2008cites this paper
• Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.

  2008cites this paper
• Thrombocytosis in the neonatal intensive care unit: Experience at a single center.

  2007cites this paper
• Anaemia in heart failure: a common interaction with renal insufficiency called the cardio‐renal anaemia syndrome

  2007cites this paper